5 Best Biotech ETFs To Buy

4. Putnam BioRevolution ETF (NYSE:SYNB)

5-Year Share Price Performance as of April 2: 24.63%

Ranking 4th on our list of the best biotech ETFs is Putnam BioRevolution ETF (NYSE:SYNB). Putnam BioRevolution ETF (NYSE:SYNB) aims to achieve long-term capital growth by investing in a portfolio of 30-50 carefully selected stocks. As of March 31, 2024, the fund has net assets of $5.43 million, along with an expense ratio of 0.70%. Its portfolio consists of 35 stocks. Putnam BioRevolution ETF (NYSE:SYNB) is one of the best biotech ETFs to buy. 

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the top holdings of the Putnam BioRevolution ETF (NYSE:SYNB). Thermo Fisher Scientific Inc. (NYSE:TMO) is a global provider of life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. On February 21, Thermo Fisher Scientific Inc. (NYSE:TMO) declared a $0.39 per share quarterly dividend, an 11.4% increase from its prior dividend of $0.35. The dividend is payable on April 15, to shareholders on record as of March 15. 

According to Insider Monkey’s fourth quarter database, 111 hedge funds were bullish on Thermo Fisher Scientific Inc. (NYSE:TMO), compared to 109 funds in the prior quarter. 

Generation Investment Global Equity Strategy stated the following regarding Thermo Fisher Scientific Inc. (NYSE:TMO) in its fourth quarter 2023 investor letter:

“In each quarterly letter we share examples from the portfolio that bring our investment process to life. This quarter we focus on Thermo Fisher Scientific Inc. (NYSE:TMO), a provider of healthcare products.

In recent years advances have accelerated. The large-scale use of mRNA vaccines during the COVID pandemic – the first major application of these vaccines – is just one example. Similar advances in drug development have allowed medicines to be developed for hard-to-treat diseases like Alzheimer’s, as well as to treat and perhaps cure diseases that previously eluded treatment.

To push innovation forward, researchers need tools to ask the right questions, run experiments to test hypotheses and in turn draw insights. These tools encompass high-specification instruments, high-purity reagents, powerful software and a variety of specialized services. An ecosystem has developed of companies that specialize in providing these tools. We often think of them as providing the ‘picks-and-shovels’ to researchers who are mining for the gold once obscured by nature…” (Click here to read the full text)